TB-500 TB-500 is a synthetic fragment modeled after the naturally occurring protein Thymosin Beta-4
2023 Ludvik B, Giorgino F, Jodar E et al (2021) Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity
Read how we tame the toughest tummies in Oklahoma with our related read
And for those using BPC-157 or TB-500 for recovery alongside their GLP-1 therapy, the BPC-157 and TB-500 stacking guide along with the BPC-157 versus TB-500 comparison provides detailed guidance on combining these compounds safely
This multi-receptor agonism means that Retatrutide helps reduce food intake by prolonging feelings of fullness slows gastric emptying elevates energy usage by modulating glucagon action and supports insulin secretion when glucose levels are high
